Display Settings:

Format

Send to:

Choose Destination
    Exp Mol Med. 2011 Jun 30;43(6):323-33.

    Phenylpropanoids in radioregulation: double edged sword.

    Source

    College of Natural Sciences Department of Biological Sciences Pusan National University Busan 609-735, Korea.

    Abstract

    Radiotherapy, frequently used for treatment of solid tumors, carries two main obstacles including acquired radioresistance in cancer cells during radiotherapy and normal tissue injury. Phenylpropanoids, which are naturally occurring phytochemicals found in plants, have been identified as potential radiotherapeutic agents due to their anti-cancer activity and relatively safe levels of cytotoxicity. Various studies have proposed that these compounds could not only sensitize cancer cells to radiation resulting in inhibition of growth and cell death but also protect normal cells against radiation-induced damage. This review is intended to provide an overview of recent investigations on the usage of phenylpropanoids in combination with radiotherapy in cancer treatment.

    PMID:
    21483230
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3128910
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1
    Figure 2

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk